Raymond James analyst Andrew Cooper raised the firm’s price target on Thermo Fisher to $660 from $650 and keeps an Outperform rating on the shares. Results were on the high side of expectations and included few dramatic surprises, and while the firm would have liked more of a guidance raise, in this environment the Q2 beat and raise should be enough, the analyst tells investors in a research note. End market commentary remains upbeat that recovery is a matter of when, not if, though exact pacing of normalization is still somewhat fluid, the firm says.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
